Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
9.91%
operating margin TTM
12.23%
revenue TTM
597.54 Million
revenue per share TTM
18.97$
valuation ratios | |
|---|---|
| pe ratio | 106.97 |
| peg ratio | -0.53 |
| price to book ratio | 41.62 |
| price to sales ratio | 10.59 |
| enterprise value multiple | 51.55 |
| price fair value | 41.62 |
profitability ratios | |
|---|---|
| gross profit margin | 66.41% |
| operating profit margin | 12.23% |
| pretax profit margin | 14.7% |
| net profit margin | 9.91% |
| return on assets | 34.03% |
| return on equity | 5.37% |
| return on capital employed | 45.4% |
liquidity ratios | |
|---|---|
| current ratio | 3.86 |
| quick ratio | 2.65 |
| cash ratio | 1.62 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 28.53 |
| operating cycle | 36.77 |
| days of payables outstanding | 22.18 |
| cash conversion cycle | 14.60 |
| receivables turnover | 44.27 |
| payables turnover | 16.46 |
| inventory turnover | 12.79 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.06 |
| long term debt to capitalization | 0.05 |
| total debt to capitalization | 0.05 |
| interest coverage | 34.93 |
| cash flow to debt ratio | 18.85 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.50 |
| cash per share | 0.99 |
| operating cash flow per share | 7.47 |
| free cash flow operating cash flow ratio | 0.60 |
| cash flow coverage ratios | 18.85 |
| short term coverage ratios | 196.03 |
| capital expenditure coverage ratio | 1.31 |
Frequently Asked Questions
When was the last time Xvivo Perfusion AB (publ) (PNK:XVIPF) reported earnings?
Xvivo Perfusion AB (publ) (XVIPF) published its most recent earnings results on 30-06-2026.
What is Xvivo Perfusion AB (publ)'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Xvivo Perfusion AB (publ) (PNK:XVIPF)'s trailing twelve months ROE is 5.37%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Xvivo Perfusion AB (publ) (XVIPF) currently has a ROA of 34.03%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did XVIPF's net profit margin stand at?
XVIPF reported a profit margin of 9.91% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is XVIPF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.86 in the most recent quarter. The quick ratio stood at 2.65, with a Debt/Eq ratio of 0.06.